FEMA5:Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. | To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. | ||
__TOC__ | __TOC__ | ||
{| class="wikitable" style="margin:auto" | {| class="wikitable" style="margin:auto" | ||
| Line 18: | Line 19: | ||
!'''Notes''' | !'''Notes''' | ||
|- | |- | ||
|CHAPTER 2 (TUMOURS OF THE OVARY) | | | ||
==== CHAPTER 2 (TUMOURS OF THE OVARY) ==== | |||
| | | | ||
---- | ---- | ||
| Line 808: | Line 810: | ||
| | | | ||
|- | |- | ||
|CHAPTER 3 (ENDOMETRIOSIS AND RELATED CONDITIONS) | | | ||
==== CHAPTER 3 (ENDOMETRIOSIS AND RELATED CONDITIONS) ==== | |||
| | | | ||
---- | ---- | ||
| Line 839: | Line 842: | ||
| | | | ||
|- | |- | ||
|CHAPTER 4 (TUMOURS OF THE PERITONEUM) | | | ||
==== CHAPTER 4 (TUMOURS OF THE PERITONEUM) ==== | |||
| | | | ||
---- | ---- | ||
| Line 1,123: | Line 1,127: | ||
| | | | ||
|- | |- | ||
|CHAPTER 5 (TUMOURS OF THE FALLOPIAN TUBE) | | | ||
==== CHAPTER 5 (TUMOURS OF THE FALLOPIAN TUBE) ==== | |||
| | | | ||
---- | ---- | ||
| Line 1,297: | Line 1,302: | ||
| | | | ||
|- | |- | ||
|CHAPTER 6 (TUMOURS OF THE BROAD LIGAMENT AND OTHER UTERINE LIGAMENTS) | | | ||
==== CHAPTER 6 (TUMOURS OF THE BROAD LIGAMENT AND OTHER UTERINE LIGAMENTS) ==== | |||
| | | | ||
---- | ---- | ||
| Line 1,405: | Line 1,411: | ||
| | | | ||
|- | |- | ||
|CHAPTER 7 (TUMOURS OF THE UTERINE CORPUS) | | | ||
==== CHAPTER 7 (TUMOURS OF THE UTERINE CORPUS) ==== | |||
| | | | ||
---- | ---- | ||
| Line 1,744: | Line 1,751: | ||
| | | | ||
|- | |- | ||
|CHAPTER 8 (GESTATIONAL TROPHOBLASTIC DISEASE) | | | ||
==== CHAPTER 8 (GESTATIONAL TROPHOBLASTIC DISEASE) ==== | |||
| | | | ||
---- | ---- | ||
| Line 1,874: | Line 1,882: | ||
| | | | ||
|- | |- | ||
|CHAPTER 9 (TUMOURS OF THE UTERINE CERVIX) | | | ||
==== CHAPTER 9 (TUMOURS OF THE UTERINE CERVIX) ==== | |||
| | | | ||
---- | ---- | ||
| Line 2,235: | Line 2,244: | ||
| | | | ||
|- | |- | ||
|CHAPTER 10 (TUMOURS OF THE VAGINA) | | | ||
==== CHAPTER 10 (TUMOURS OF THE VAGINA) ==== | |||
| | | | ||
---- | ---- | ||
| Line 2,508: | Line 2,518: | ||
| | | | ||
|- | |- | ||
|CHAPTER 11 (TUMOURS OF THE VULVA) | | | ||
==== CHAPTER 11 (TUMOURS OF THE VULVA) ==== | |||
| | | | ||
---- | ---- | ||
| Line 2,737: | Line 2,748: | ||
| | | | ||
|- | |- | ||
|CHAPTER 12 (NEUROENDOCRINE NEOPLASIA) | | | ||
==== CHAPTER 12 (NEUROENDOCRINE NEOPLASIA) ==== | |||
| | | | ||
---- | ---- | ||
| Line 2,801: | Line 2,813: | ||
| | | | ||
|- | |- | ||
|CHAPTER 13 (HAEMATOLYMPHOID PROLIFERATIONS AND NEOPLASIA) | | | ||
==== CHAPTER 13 (HAEMATOLYMPHOID PROLIFERATIONS AND NEOPLASIA) ==== | |||
| | | | ||
---- | ---- | ||
| Line 2,887: | Line 2,900: | ||
| | | | ||
|- | |- | ||
|CHAPTER 14 (MESENCHYMAL TUMOURS OF THE LOWER GENITAL TRACT) | | | ||
==== CHAPTER 14 (MESENCHYMAL TUMOURS OF THE LOWER GENITAL TRACT) ==== | |||
| | | | ||
---- | ---- | ||
| Line 3,204: | Line 3,218: | ||
| | | | ||
|- | |- | ||
|CHAPTER 15 (MELANOCYTIC LESIONS) | | | ||
==== CHAPTER 15 (MELANOCYTIC LESIONS) ==== | |||
| | | | ||
---- | ---- | ||
| Line 3,290: | Line 3,305: | ||
| | | | ||
|- | |- | ||
|CHAPTER 16 (METASTASIS) | | | ||
==== CHAPTER 16 (METASTASIS) ==== | |||
| | | | ||
---- | ---- | ||
| Line 3,321: | Line 3,337: | ||
| | | | ||
|- | |- | ||
|CHAPTER 17 (GENETIC TUMOUR SYNDROMES OF THE FEMALE GENITAL TRACT) | | | ||
==== CHAPTER 17 (GENETIC TUMOUR SYNDROMES OF THE FEMALE GENITAL TRACT) ==== | |||
| | | | ||
---- | ---- | ||